Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF vs DENTSPLY SIRONA Inc — how do they compare? Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.62 (market cap $7.77B), while DENTSPLY SIRONA Inc trades at $8.85 (market cap $1.73B). The key difference: Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is far larger — about 4.5× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF for 56 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| PDBC | XRAY | |
|---|---|---|
Market Cap | $7.77B | $1.73B |
Volume | 6,100,303 | 6,198,582 |
52-Week High | $20.10 | $14.68 |
52-Week Low | $13.16 | $8.52 |
Typical Hold Time | 56 Days | 72 Days |
Sector | — | Health |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
PDBC (Invesco Optimum Yield Diversified Commodity Strategy ETF) trades at $19.68, up 1.39% with strong bullish momentum. The ETF has delivered exceptional performance, rising 45.66% year-to-date driven by energy and agricultural gains amid geopolitical turmoil. Technical indicators show bullish moving averages but neutral oscillators, with RSI at 72.89 suggesting potential overbought conditions. Recent institutional activity shows significant position increases despite a 215% surge in short interest.
The outlook remains positive given strong commodity trends and defensive positioning appeal, though elevated short interest and geopolitical risks warrant caution. Commodity exposure provides inflation hedge benefits, but price volatility and concentrated sector risks require careful monitoring for investors seeking diversified commodity exposure.
Dentsply Sirona (XRAY) trades at $8.73, near its 52-week low, with a bearish technical signal and negative profitability metrics. The company reported a Q2 2026 earnings beat but faces declining revenue and negative net income margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid a challenging dental market environment.
The outlook remains cautious due to persistent margin pressure and sales declines, though the consensus price target of $13.40 suggests potential upside. Key risks include competitive pressures and execution of the turnaround plan, while institutional buying indicates some long-term confidence.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →